研究单位：[1]Reistone Biopharma Company Limited[2]Quest Dermatology Research,Northridge,California,United States,91324[3]Moore Clinical Research,Brandon,Florida,United States,33511[4]Dawes Fretzin Clinical Research,Indianapolis,Indiana,United States,46250[5]Skin Search of Rochester, Inc,Rochester,New York,United States,14623[6]Dermatologists of Southwest Ohio,Mason,Ohio,United States,45040[7]The Skin Wellness Center,Knoxville,Tennessee,United States,37922[8]Progressive Clinical Research,San Antonio,Texas,United States,78213[9]St George Dermatology and Skin Cancer Centre,Kogarah,New South Wales,Australia,2217[10]Novatrials,Kogarah,New South Wales,Australia,2289[11]Veracity Clinical Research,Woolloongabba,Queensland,Australia,4102[12]Skin Health Institute,Carlton,Victoria,Australia,3053[13]Sinclair Dermatology,East Melbourne,Victoria,Australia,3002[14]Sinclair Dermatology,Melbourne,Victoria,Australia,3002[15]China-Japan Friendship Hospital,Beijing,China,100029[16]Peking University First Hospital,Beijing,China,100034[17]Peking University People's Hospital,Beijing,China,100044[18]Beijing Friendship Hospital, Capital Medical University,Beijing,China,100050[19]Beijing Tongren Hospital, Capital Medical University,Beijing,China,100730[20]Beijing Friendship Hospital, Capital Medical University,Beijing,China[21]Beijing Tongren Hospital, Capital Medical University,Beijing,China[22]Peking University People's Hospital,Beijing,China[23]Chongqing Traditional Chinese medicine Hospital,Chongqing,Chongqing,China,400011[24]The First Affiliated Hospital of Chongqing Medical University,Chongqing,Chongqing,China,400016[25]The First Affiliated Hospital of Fujian Medical University,Fuzhou,Fujian,China,350005[26]Guangdong Provincial People's Hospital,Guangzhou,Guangdong,China,510030[27]The Dermatology Hospital of Nanfang Medical University,Guangzhou,Guangdong,China[28]The Dermatology Hospital of Nanfang Medical University,Guangzhou,Guangzhou,China[29]Henan Provincial People's Hospital,Zhengzhou,Henan,China,450003[30]Jiangsu Province People's Hospital,Nanjin,Jiangsu,China,210029[31]The First Hospital of China Medical University,Shenyang,Liaoning,China,110001[32]Shanghai Skin Disease Hospital,Shanghai,Shanghai,China,200071[33]Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital,Tianjin,China,300120[34]The First Affiliated Hospital of Zhejiang University,Hangzhou,Zhejiang,China,310003[35]SIR RUN RUN Shaw Hospital Zhejiang University School of Medicine,Hangzhou,Zhejiang,China,310020
研究目的：
This is a global Phase 2 study to evaluate the safety and effectiveness of an investigational study drug (called SHR0302) in adults with moderate to severe alopecia areata.
